Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marju Tilly-Kiesi"'
Autor:
Marie-Claude Blatter Garin, Laura Calabresi, Marja-Riitta Taskinen, Marju Tilly-Kiesi, Richard W. James, Gerd Assmann, Arnold von Eckardstein, Guido Franceschini, Roberto Miccoli
Publikováno v:
Atherosclerosis. 139:77-82
Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the protection of low density lipoproteins (LDL) from oxidative stress. The present study examined paraoxonase in several genetically distinct HDL deficienc
Autor:
Gregory G. Dolnikowski, Jose M. Ordovas, Marja-Riitta Taskinen, Ernst J. Schaefer, Raija Malmström, Alice H. Lichtenstein, Marju Tilly-Kiesi
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 17:873-880
Abstract Our purpose was to examine HDL metabolism in a Finnish kindred with a 3-bp deletion in the apolipoprotein (apo) A-I gene, resulting in a deletion of Lys 107 in the mature apoA-I. Patients with this mutation [apoA-I(Lys 107 →0)] have reduce
Autor:
Christopher J. Packard, Christian Ehnholm, James Shepherd, Marju Tilly-Kiesi, Juhani Kahri, Marja-Riitta Taskinen
Publikováno v:
Atherosclerosis. 128:213-222
Apolipoprotein A-I (apo A-I) and apolipoprotein A-II (apo A-II) represent 80 90% of the protein content of high density lipoproteins (HDL). Previously we have identified a Finnish family with an apo A-I variant (Lys107-->0) associated with reduced pl
Autor:
Marju Tilly-Kiesi, P. Knudsen, Juhani Kahri, Marja-Riitta Taskinen, S. Lahdenperä, Christian Ehnholm, Antikainen M, H Tenkanen, A Bensadoun, M Uusi-Oukari, Ehnholm S
Publikováno v:
Europe PubMed Central
Journal of Lipid Research, Vol 37, Iss 4, Pp 825-834 (1996)
Journal of Lipid Research, Vol 37, Iss 4, Pp 825-834 (1996)
We have characterized the molecular basis for familial hepatic lipase (HL) deficiency in a Finnish family. In the propositus, the HL deficiency results from compound heterozygosity for two rare HL gene mutations, a previously unknown missense mutatio
Publikováno v:
Europe PubMed Central
Journal of Lipid Research, Vol 37, Iss 7, Pp 1569-1578 (1996)
Journal of Lipid Research, Vol 37, Iss 7, Pp 1569-1578 (1996)
We studied the subclasses of plasma lipoproteins in normolipidemic, glucose-tolerant male relatives of noninsulin dependent diabetic patients (NIDDM), who represented either the lowest (n = 14) or the highest (n = 18) quintiles of fasting plasma insu
Autor:
Giancarlo Viberti, Marja-Riitta Taskinen, Per-Henrik Groop, S. Lahdenperä, Tom Elliott, Timo Kuusi, Marju Tilly-Kiesi
Publikováno v:
Diabetologia. 37:681-688
To answer the question whether the elevation of LDL-cholesterol in IDDM patients with incipient and established diabetic nephropathy is accompanied by changes in LDL size or composition, we studied distribution of LDL particles in 57 normoalbuminuric
Autor:
Marja-Riitta Taskinen, Timo Kuusi, Marju Tilly-Kiesi, Helena Vuorinen-Markkola, S. Lahdenperä
Publikováno v:
Diabetes Care. 16:584-592
OBJECTIVE To study the effects of gemfibrozil treatment on LDL particle size, density distribution, and composition in NIDDM patients. RESEARCH DESIGN AND METHODS We performed LDL analyses on 16 NIDDM patients with stable glycemic control. They were
Autor:
Marju Tilly-Kiesi
Publikováno v:
Metabolism. 40:623-628
The effects of lovastatin treatment on density distribution and composition of low-density lipoproteins (LDL) were studied using a density gradient ultracentrifugation method in 35 hypercholesterolemic patients with severe peripheral vascular disease
Autor:
P. Knudsen, Marju Tilly-Kiesi, Ernst J. Schaefer, Marja-Riitta Taskinen, Gregory G. Dolnikowski, Francine K. Welty, Alice H. Lichtenstein
Publikováno v:
Metabolism: clinical and experimental. 53(4)
A heritable deficiency of hepatic lipase (HL) provides insights into the physiologic function of HL in vivo. The metabolism of apolipoprotein B (apoB)-100 in very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density
Publikováno v:
Atherosclerosis. 137(1)
Subjects with apoA-I(Lys107--0) deletion mutation have reduced levels of plasma HDL cholesterol, apoA-I, apoA-II and Lp(AI:AII). In the present study were describe the postprandial responses of apoA-I(Lys107--0) subjects (n=6) to the ingestion of a f